Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

See Locations Near You

Summary

The primary purpose of this study is to evaluate the safety, side effects, and dosage for Motexafin Gadolinium given with the chemotherapy drug docetaxel to patients with advanced cancers. Secondly, tumor response to the combined treatment, drug levels in the body, and drug interactions will be evaluated.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

At least 18 years old
Metastatic, or unresectable solid tumors from breast, head, and neck, gastrointestinal, genitourinary, lung, or ovarian cancer or recurrent glioblastoma multiforme
ECOG performance status score either 0, 1, or 2
Willing and able to provide written informed consent

Exclusion Criteria:

Greater than two prior cytotoxic regimens
Laboratory values showing adequate function of bone marrow, liver, and kidneys
Uncontrolled hypertension
Known sensitivity to or intolerable adverse effects from taxanes (eg. paclitaxel, docetaxel) or polysorbate 80

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

25

Study ID:

NCT00120939

Recruitment Status:

Completed

Sponsor:

Pharmacyclics LLC.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

25

Study ID:

NCT00120939

Recruitment Status:

Completed

Sponsor:


Pharmacyclics LLC.

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider